{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:38:40Z","timestamp":1791952720334,"version":"4.3.4"},"reference-count":90,"publisher":"American Animal Hospital Association","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    A substantial number of cats develop diabetes mellitus (DM), a serious endocrine disorder that can lead to other physiologic complications. While DM management can be complex, successful control that alleviates the patient\u2019s clinical signs and avoids hypoglycemia is achievable in most cats. Diabetic remission is also possible. The\n                    <jats:italic>2026 AAHA Diabetes Management Guidelines for Cats<\/jats:italic>\n                    retain clinically relevant information from the\n                    <jats:italic>2018 AAHA Diabetes Management Guidelines<\/jats:italic>\n                    and present new findings and expert opinions. Subjects such as pathophysiology, diagnosis, how to treat and monitor cats receiving SGLT2 inhibitors, various insulin options for cats, how to monitor cats receiving insulin, diet and physical activity recommendations, advantages and disadvantages of at-home glucose monitoring devices, diagnosing and treating diabetic ketoacidosis, and client education are all discussed. The guidelines also cover how to identify patients who are at risk of developing DM and how to differentiate DM from transient or mild hyperglycemia.\n                  <\/jats:p>","DOI":"10.5326\/jaaha-ms-7572","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T02:17:25Z","timestamp":1776824245000},"page":"65-93","source":"Crossref","is-referenced-by-count":2,"title":["2026 AAHA Diabetes Management Guidelines for Cats"],"prefix":"10.5326","volume":"62","author":[{"given":"Andrew","family":"Bugbee","sequence":"first","affiliation":[{"name":"Texas A&M University, College Station, Texas (A.B.);"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee","family":"Rucinsky","sequence":"additional","affiliation":[{"name":"Mid Atlantic Cat Hospital, Mid Atlantic Feline Thyroid Center, Queenstown, Maryland (R.R.);"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Alvarez","sequence":"additional","affiliation":[{"name":"University of Wisconsin \u2013 Madison, Madison, Wisconsin (E.A.);"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Cook","sequence":"additional","affiliation":[{"name":"Texas A&M University, College Station, Texas (A.C.);"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patty","family":"Lathan","sequence":"additional","affiliation":[{"name":"Louisiana State University, Baton Rouge, Louisiana (P.L.);"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassie","family":"Panning","sequence":"additional","affiliation":[{"name":"Minneapolis, Minnesota (C.P.)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3280","reference":[{"issue":"1","key":"i1547-3317-62-3-65-b1","series-title":"J Am Anim Hosp Assoc.","first-page":"1","article-title":"2018 AAHA Diabetes Management Guidelines for Dogs and Cats","volume":"54","author":"Behrend","year":"2018","unstructured":"Behrend E, Holford A, Lathan P, Rucinsky R, Schulman R. 2018 AAHA Diabetes Management Guidelines for Dogs and Cats. J Am Anim Hosp Assoc. 2018;54(1):1\u201321."},{"issue":"3","key":"i1547-3317-62-3-65-b2","series-title":"Vet Clin North Am Small Anim Pract","first-page":"511","article-title":"Pathophysiology of prediabetes, diabetes, and diabetic remission in cats","volume":"53","author":"Gostelow","year":"2023","unstructured":"Gostelow R, Hazuchova K. Pathophysiology of prediabetes, diabetes, and diabetic remission in cats. Vet Clin North Am Small Anim Pract 2023;53(3):511\u201329."},{"issue":"2","key":"i1547-3317-62-3-65-b3","series-title":"Vet Clin North Am Small Anim Pract.","first-page":"221","article-title":"Pathogenesis of feline diabetes","volume":"43","author":"Rand","year":"2013","unstructured":"Rand JS. Pathogenesis of feline diabetes. Vet Clin North Am Small Anim Pract. 2013;43(2):221\u2013231."},{"issue":"5","key":"i1547-3317-62-3-65-b4","series-title":"Nutr Metab Cardiovasc Dis","first-page":"365","article-title":"Glucose toxicity: the leading actor in the pathogenesis and clinical history of type 2 diabetes\u2013mechanisms and potentials for treatment","volume":"19","author":"Giaccari","year":"2009","unstructured":"Giaccari A, Sorice G, Muscogiuri G. Glucose toxicity: the leading actor in the pathogenesis and clinical history of type 2 diabetes\u2013mechanisms and potentials for treatment. Nutr Metab Cardiovasc Dis 2009;19(5):365\u201377."},{"key":"i1547-3317-62-3-65-b5","series-title":"Diabetologia","first-page":"336","article-title":"Hyperglycaemia but not hyperlipidaemia causes beta cell dysfunction and beta cell loss in the domestic cat","volume":"52","author":"Zini","year":"2009","unstructured":"Zini E, Osto M, Franchini M,  Hyperglycaemia but not hyperlipidaemia causes beta cell dysfunction and beta cell loss in the domestic cat. Diabetologia 2009;52:336\u201346."},{"key":"i1547-3317-62-3-65-b6","series-title":"Gen Comp Endocrinol","first-page":"269","article-title":"The effect of experimentally induced chronic hyperglycaemia on serum and pancreatic insulin, pancreatic islet IGF-I and plasma and urinary ketones in the domestic cat (Felis felis)","volume":"188","author":"Link","year":"2013","unstructured":"Link KR, Allio I, Rand JS,  The effect of experimentally induced chronic hyperglycaemia on serum and pancreatic insulin, pancreatic islet IGF-I and plasma and urinary ketones in the domestic cat (Felis felis). Gen Comp Endocrinol 2013;188:269\u201381."},{"issue":"10","key":"i1547-3317-62-3-65-b7","series-title":"J Neuropathol Exp Neurol.","first-page":"872","article-title":"Neurological complications associated with spontaneously occurring feline diabetes mellitus","volume":"61","author":"Mizisin","year":"2002","unstructured":"Mizisin AP, Shelton GD, Burgers ML, Powell HC, Cuddon PA. Neurological complications associated with spontaneously occurring feline diabetes mellitus. J Neuropathol Exp Neurol. 2002;61(10):872\u2013884."},{"issue":"5","key":"i1547-3317-62-3-65-b8","series-title":"J Feline Med Surg","first-page":"351","article-title":"Time trends and risk factors for diabetes mellitus in cats presented to veterinary teaching hospitals","volume":"9","author":"Prahl","year":"2007","unstructured":"Prahl A, Guptill L, Glickman NW,  Time trends and risk factors for diabetes mellitus in cats presented to veterinary teaching hospitals. J Feline Med Surg 2007;9(5):351\u20138."},{"key":"i1547-3317-62-3-65-b9","series-title":"Canine & Feline Endocrinology.","first-page":"271","author":"Reusch","year":"2015","unstructured":"Reusch CE. Feline Diabetes Mellitus. In: Canine & Feline Endocrinology. 4th ed. Elsevier; 2015:271\u20133."},{"issue":"4","key":"i1547-3317-62-3-65-b10","series-title":"PLoS One.","first-page":"e0249322","article-title":"Differences in metabolic profiles between the Burmese, the Maine coon and the Birman cat-Three breeds with varying risk for diabetes mellitus","volume":"16","author":"\u00d6hlund","year":"2021","unstructured":"\u00d6hlund M, M\u00fcllner E, Moazzami A,  Differences in metabolic profiles between the Burmese, the Maine coon and the Birman cat-Three breeds with varying risk for diabetes mellitus. PLoS One. 2021;16(4):e0249322."},{"issue":"1","key":"i1547-3317-62-3-65-b11","series-title":"J Vet Intern Med.","first-page":"29","article-title":"Environmental risk factors for diabetes mellitus in cats","volume":"31","author":"\u00d6hlund","year":"2017","unstructured":"\u00d6hlund M, Egenvall A, Fall T,  Environmental risk factors for diabetes mellitus in cats. J Vet Intern Med. 2017;31(1):29\u201335."},{"issue":"2","key":"i1547-3317-62-3-65-b12","series-title":"J Vet Intern Med","first-page":"123","article-title":"Acute stress hyperglycemia in cats is associated with struggling and increased concentrations of lactate and norepinephrine","volume":"16","author":"Rand","year":"2002","unstructured":"Rand JS, Kinnaird E, Baglioni A,  Acute stress hyperglycemia in cats is associated with struggling and increased concentrations of lactate and norepinephrine. J Vet Intern Med 2002;16(2):123\u201332."},{"key":"i1547-3317-62-3-65-b13","series-title":"Domest Anim Endocrinol.","first-page":"55","article-title":"Diagnosis of prediabetes in cats: glucose concentration cut points for impaired fasting glucose and impaired glucose tolerance","volume":"57","author":"Reeve-Johnson","year":"2016","unstructured":"Reeve-Johnson MK, Rand JS, Vankan D, Anderson ST, Marshall R, Morton JM. Diagnosis of prediabetes in cats: glucose concentration cut points for impaired fasting glucose and impaired glucose tolerance. Domest Anim Endocrinol. 2016;57:55\u201362."},{"key":"i1547-3317-62-3-65-b14","series-title":"Vet J","first-page":"105910","article-title":"Agreeing Language In Veterinary Endocrinology (ALIVE): diabetes mellitus-a modified Delphi-method-based system to create consensus disease definitions","volume":"289","author":"Niessen","year":"2022","unstructured":"Niessen SJM, Bjornvad C, Church DB, et\u00a0al; ESVE\/SCE membership. Agreeing Language In Veterinary Endocrinology (ALIVE): diabetes mellitus-a modified Delphi-method-based system to create consensus disease definitions. Vet J 2022;289:105910."},{"issue":"6","key":"i1547-3317-62-3-65-b15","series-title":"J Feline Med Surg","first-page":"583","article-title":"Changes in blood glucose concentration are associated with relatively rapid changes in circulating fructosamine concentrations in cats","volume":"10","author":"Link","year":"2008","unstructured":"Link KR, Rand JS. Changes in blood glucose concentration are associated with relatively rapid changes in circulating fructosamine concentrations in cats. J Feline Med Surg 2008;10(6):583\u201392."},{"issue":"3","key":"i1547-3317-62-3-65-b16","series-title":"Vet Clin Pathol","first-page":"322","article-title":"The effects of body weight, body condition score, sex, and age on serum fructosamine concentrations in clinically healthy cats","volume":"39","author":"Gilor","year":"2010","unstructured":"Gilor C, Graves TK, Lascelles BDX,  The effects of body weight, body condition score, sex, and age on serum fructosamine concentrations in clinically healthy cats. Vet Clin Pathol 2010;39(3):322\u20138."},{"issue":"12","key":"i1547-3317-62-3-65-b17","series-title":"Vet Rec","first-page":"370","article-title":"Evaluation of fructosamine in dogs and cats with hypo\u2010 or hyperproteinaemia, azotaemia, hyperlipidaemia and hyperbilirubinaemia","volume":"148","author":"Reusch","year":"2001","unstructured":"Reusch CE, Haberer B. Evaluation of fructosamine in dogs and cats with hypo\u2010 or hyperproteinaemia, azotaemia, hyperlipidaemia and hyperbilirubinaemia. Vet Rec 2001;148(12):370\u20136."},{"issue":"9","key":"i1547-3317-62-3-65-b18","series-title":"J Am Vet Med Assoc","first-page":"1297","article-title":"Serum fructosamine concentration in cats with overt hyperthyroidism","volume":"215","author":"Reusch","year":"1999","unstructured":"Reusch CE, Tomsa K. Serum fructosamine concentration in cats with overt hyperthyroidism. J Am Vet Med Assoc 1999 1;215(9):1297\u2013300."},{"issue":"3","key":"i1547-3317-62-3-65-b19","series-title":"J Vet Intern Med","first-page":"161","article-title":"Glycosylated hemoglobin concentration for assessment of glycemic control in diabetic cats","volume":"11","author":"Elliott","year":"1997","unstructured":"Elliott DA, Nelson RW, Feldman EC,  Glycosylated hemoglobin concentration for assessment of glycemic control in diabetic cats. J Vet Intern Med 1997;11(3):161\u20135."},{"issue":"3","key":"i1547-3317-62-3-65-b20","series-title":"Vet Clin Pathol","first-page":"531","article-title":"Establishment of a feline glycated hemoglobin reference interval for a novel dried\u2010blood\u2010spot-assay and the effects of anemia on assay results","volume":"52","author":"Mott","year":"2023","unstructured":"Mott J, Dolan JK, Gilor C,  Establishment of a feline glycated hemoglobin reference interval for a novel dried\u2010blood\u2010spot-assay and the effects of anemia on assay results. Vet Clin Pathol 2023;52(3):531\u20139."},{"key":"i1547-3317-62-3-65-b21","series-title":"J Vet Pharmacol Ther","first-page":"19","article-title":"SGLT2 inhibitor use in the management of feline diabetes mellitus","volume":"48","author":"Cook","year":"2025","unstructured":"Cook AK, Behrend E. SGLT2 inhibitor use in the management of feline diabetes mellitus. J Vet Pharmacol Ther 2025;48(Suppl 1):19\u201330."},{"key":"i1547-3317-62-3-65-b22","series-title":"Vet J","first-page":"8","article-title":"International Society for Companion Animal Infectious Diseases (ISCAID) guidelines for the diagnosis and management of bacterial urinary tract infections in dogs and cats","volume":"247","author":"Weese","year":"2019","unstructured":"Weese JS, Blondeau J, Boothe D,  International Society for Companion Animal Infectious Diseases (ISCAID) guidelines for the diagnosis and management of bacterial urinary tract infections in dogs and cats. Vet J 2019;247:8\u201325."},{"issue":"3","key":"i1547-3317-62-3-65-b23","series-title":"Vet Clin North Am Small Anim Pract","first-page":"691","article-title":"Hypersomatotropism and other causes of insulin resistance in cats","volume":"53","author":"Niessen","year":"2023","unstructured":"Niessen SJ. Hypersomatotropism and other causes of insulin resistance in cats. Vet Clin North Am Small Anim Pract 2023;53(3):691\u2013710."},{"issue":"12","key":"i1547-3317-62-3-65-b24","series-title":"J Feline Med Surg.","first-page":"1181","article-title":"Cutpoints for screening blood glucose concentrations in healthy senior cats","volume":"19","author":"Reeve-Johnson","year":"2017","unstructured":"Reeve-Johnson MK, Rand JS, Vankan D, Anderson ST, Marshall R, Morton JM. Cutpoints for screening blood glucose concentrations in healthy senior cats. J Feline Med Surg. 2017;19(12):1181\u20131191."},{"key":"i1547-3317-62-3-65-b25","series-title":"J Anim Physiol Anim Nutr (Berl)","first-page":"427","article-title":"Using environmental and feeding enrichment to facilitate feline weight loss","volume":"89","author":"Clarke","year":"2005","unstructured":"Clarke DL, Wrigglesworth D, Holmes K,  Using environmental and feeding enrichment to facilitate feline weight loss. J Anim Physiol Anim Nutr (Berl) 2005;89:427."},{"issue":"4","key":"i1547-3317-62-3-65-b26","series-title":"J Feline Med Surg.","first-page":"211","article-title":"Insulin sensitivity decreases with obesity, and lean cats with low insulin sensitivity are at greatest risk of glucose intolerance with weight gain","volume":"3","author":"Appleton","year":"2001","unstructured":"Appleton DJ, Rand JS, Sunvold GD. Insulin sensitivity decreases with obesity, and lean cats with low insulin sensitivity are at greatest risk of glucose intolerance with weight gain. J Feline Med Surg. 2001;3(4):211\u2013228."},{"issue":"3","key":"i1547-3317-62-3-65-b27","series-title":"Domest Anim Endocrinol.","first-page":"129","article-title":"Effects of weight loss in obese cats on biochemical analytes related to inflammation and glucose homeostasis","volume":"42","author":"Tvarijonaviciute","year":"2012","unstructured":"Tvarijonaviciute A, Ceron JJ, Holden SL, Morris PJ, Biourge V, German AJ. Effects of weight loss in obese cats on biochemical analytes related to inflammation and glucose homeostasis. Domest Anim Endocrinol. 2012;42(3):129\u2013141."},{"issue":"10","key":"i1547-3317-62-3-65-b28","series-title":"J Am Vet Med Assoc","first-page":"1343","article-title":"Velagliflozin, a once-daily, liquid, oral SGLT2 inhibitor, is effective as a stand-alone therapy for feline diabetes mellitus: the SENSATION study","volume":"262","author":"Behrend","year":"2024","unstructured":"Behrend EN, Ward CR, Chukwu V,  Velagliflozin, a once-daily, liquid, oral SGLT2 inhibitor, is effective as a stand-alone therapy for feline diabetes mellitus: the SENSATION study. J Am Vet Med Assoc 2024;262(10):1343\u201353."},{"issue":"3","key":"i1547-3317-62-3-65-b29","series-title":"J Vet Intern Med","first-page":"915","article-title":"Safety and effectiveness of the sodium\u2010glucose cotransporter inhibitor bexagliflozin in cats newly diagnosed with diabetes mellitus","volume":"37","author":"Hadd","year":"2023","unstructured":"Hadd MJ, Bienhoff SE, Little SE,  Safety and effectiveness of the sodium\u2010glucose cotransporter inhibitor bexagliflozin in cats newly diagnosed with diabetes mellitus. J Vet Intern Med 2023;37(3):915\u201324."},{"issue":"4","key":"i1547-3317-62-3-65-b30","series-title":"J Vet Intern Med","first-page":"2099","article-title":"Efficacy and safety of once daily oral administration of sodium\u2010glucose cotransporter\u20102 inhibitor velagliflozin compared with twice daily insulin injection in diabetic cats","volume":"38","author":"Niessen","year":"2024","unstructured":"Niessen SJ, Kooistra HS, Forcada Y,  Efficacy and safety of once daily oral administration of sodium\u2010glucose cotransporter\u20102 inhibitor velagliflozin compared with twice daily insulin injection in diabetic cats. J Vet Intern Med 2024;38(4):2099\u2013119."},{"issue":"2","key":"i1547-3317-62-3-65-b31","series-title":"Vet Clin North Am Small Anim Pract","first-page":"407","article-title":"Oral hypoglycemics in cats with diabetes mellitus","volume":"43","author":"Palm","year":"2013","unstructured":"Palm CA, Feldman EC. Oral hypoglycemics in cats with diabetes mellitus. Vet Clin North Am Small Anim Pract 2013;43(2):407\u201315."},{"issue":"17","key":"i1547-3317-62-3-65-b32","series-title":"Animals (Basel).","first-page":"2561","article-title":"Efficacy and Safety of Non-Insulin Antidiabetic Drugs in Cats: A Systematic Review","volume":"15","author":"Romero-V\u00e9lez","year":"2025","unstructured":"Romero-V\u00e9lez F, Rejas J, Ruiz de Gopegui R. Efficacy and Safety of Non-Insulin Antidiabetic Drugs in Cats: A Systematic Review. Animals (Basel). 2025;15(17):2561."},{"issue":"1","key":"i1547-3317-62-3-65-b33","series-title":"Ann Rev Med","first-page":"255","article-title":"The mechanisms and therapeutic potential of SGLT2 inhibitors in diabetes mellitus","volume":"66","author":"Vallon","year":"2015","unstructured":"Vallon V. The mechanisms and therapeutic potential of SGLT2 inhibitors in diabetes mellitus. Ann Rev Med 2015;66(1):255\u201370."},{"issue":"1","key":"i1547-3317-62-3-65-b34","series-title":"Vet Clin Pathol","first-page":"114","article-title":"Validation of a portable hand\u2010held whole\u2010blood ketone meter for use in cats","volume":"41","author":"Weingart","year":"2012","unstructured":"Weingart C, Lotz F, Kohn B. Validation of a portable hand\u2010held whole\u2010blood ketone meter for use in cats. Vet Clin Pathol 2012;41(1):114\u20138."},{"issue":"1","key":"i1547-3317-62-3-65-b35","series-title":"J Small Anim Pract","first-page":"4","article-title":"Ketone measurements using dipstick methodology in cats with diabetes mellitus","volume":"50","author":"Zeugswetter","year":"2009","unstructured":"Zeugswetter F, Pagitz M. Ketone measurements using dipstick methodology in cats with diabetes mellitus. J Small Anim Pract 2009;50(1):4\u20138."},{"key":"i1547-3317-62-3-65-b36","article-title":"Bexacat (Bexaglifozin tablets) 15 mg flavored tablets Package insert","unstructured":"Elanco. Bexacat (Bexaglifozin tablets) 15 mg flavored tablets Package insert. Available at: https:\/\/assets-us-01.kc-usercontent.com\/e4748d51-2c24-00f7-fc54-65f3864ee8b1\/5124bb3e-2756-4160-be3d-fc08b2256fef\/PROMO_WEB_103742Asa_PA103742A_W1a_WS.pdf. Accessed June 9, 2025."},{"key":"i1547-3317-62-3-65-b37","article-title":"Senvelgo (velaglifozin oral solution) 15 mg\/ml Package insert","unstructured":"Boehringer Ingelheim. Senvelgo (velaglifozin oral solution) 15 mg\/ml Package insert. Available at: https:\/\/docs.boehringer-ingelheim.com\/SENVELGO_oral_solution_PI.pdf. Accessed June 9, 2025."},{"issue":"5","key":"i1547-3317-62-3-65-b38","series-title":"J Vet Intern Med","first-page":"e70222","article-title":"Effects of velagliflozin in 8 cats with diabetes mellitus and hypersomatotropism","volume":"39","author":"Del Baldo","year":"2025","unstructured":"Del Baldo F, Corsini A, Bresciani F,  Effects of velagliflozin in 8 cats with diabetes mellitus and hypersomatotropism. J Vet Intern Med 2025;39(5):e70222."},{"issue":"3","key":"i1547-3317-62-3-65-b39","series-title":"JNP.","article-title":"Important dietary considerations for sodium-glucose cotransporter 2 inhibitors","volume":"19","author":"Anthamatten","year":"2023","unstructured":"Anthamatten A. Important dietary considerations for sodium-glucose cotransporter 2 inhibitors. JNP. 2023;19(3)."},{"issue":"1","key":"i1547-3317-62-3-65-b40","series-title":"AACE Clin Case Rep","first-page":"30","article-title":"Sodium-glucose co-transporter protein 2 inhibitors induced hypercalcemia: a case series and literature review","volume":"8","author":"El Masri","year":"2022","unstructured":"El Masri D, Jamil Y, Eid Fares J. Sodium-glucose co-transporter protein 2 inhibitors induced hypercalcemia: a case series and literature review. AACE Clin Case Rep 2022;8(1):30\u20133."},{"issue":"2","key":"i1547-3317-62-3-65-b41","series-title":"J Feline Med Surg","first-page":"168","article-title":"Insulin glargine 300 U\/ml for the treatment of feline diabetes mellitus","volume":"24","author":"Linari","year":"2022","unstructured":"Linari G, Fleeman L, Gilor C,  Insulin glargine 300 U\/ml for the treatment of feline diabetes mellitus. J Feline Med Surg 2022;24(2):168\u201376."},{"issue":"4","key":"i1547-3317-62-3-65-b42","series-title":"Diabetes Care","first-page":"637","article-title":"New insulin glargine 300 Units \u00b7 mL-1 provides a more even activity profile and prolonged glycemic control at steady state compared with insulin glargine 100 Units \u00b7 mL-1","volume":"38","author":"Becker","year":"2015","unstructured":"Becker RH, Dahmen R, Bergmann K,  New insulin glargine 300 Units \u00b7 mL-1 provides a more even activity profile and prolonged glycemic control at steady state compared with insulin glargine 100 Units \u00b7 mL-1. Diabetes Care 2015;38(4):637\u201343."},{"issue":"5","key":"i1547-3317-62-3-65-b43","series-title":"J Vet Intern Med","first-page":"2123","article-title":"An ultra-long-acting recombinant insulin for the treatment of diabetes mellitus in cats","volume":"35","author":"Gilor","year":"2021","unstructured":"Gilor C, Hulsebosch SE, Pires J,  An ultra-long-acting recombinant insulin for the treatment of diabetes mellitus in cats. J Vet Intern Med 2021;35(5):2123\u201330."},{"key":"i1547-3317-62-3-65-b44","series-title":"Domest Anim Endocrinol","first-page":"106869","article-title":"Incretin therapy in feline diabetes mellitus - A review of the current state of research","volume":"89","author":"Haller","year":"2024","unstructured":"Haller N, Lutz TA. Incretin therapy in feline diabetes mellitus - A review of the current state of research. Domest Anim Endocrinol 2024;89:106869."},{"key":"i1547-3317-62-3-65-b45","article-title":"Freestyle Libre","unstructured":"Abbott. Freestyle Libre. Available at: https:\/\/www.freestyle.abbott\/us-en\/home.html. Accessed November 11, 2025."},{"issue":"3","key":"i1547-3317-62-3-65-b46","series-title":"Vet Clin North Am Small Anim Pract","first-page":"657","article-title":"Nutritional management of cats and dogs with diabetes mellitus","volume":"53","author":"Parker","year":"2023","unstructured":"Parker VJ, Hill RC. Nutritional management of cats and dogs with diabetes mellitus. Vet Clin North Am Small Anim Pract 2023;53(3):657\u201374."},{"issue":"2","key":"i1547-3317-62-3-65-b47","series-title":"Vet Clin North Am Small Anim Pract","first-page":"233","article-title":"The role of diet in the prevention and management of feline diabetes","volume":"43","author":"Zoran","year":"2013","unstructured":"Zoran DL, Rand JS. The role of diet in the prevention and management of feline diabetes. Vet Clin North Am Small Anim Pract 2013;43(2):233\u201343."},{"issue":"3","key":"i1547-3317-62-3-65-b48","series-title":"J Feline Med Surg","first-page":"235","article-title":"ISFM consensus guidelines on the practical management of diabetes mellitus in cats","volume":"17","author":"Sparkes","year":"2015","unstructured":"Sparkes AH, Cannon M, Church D, et\u00a0al; ISFM. ISFM consensus guidelines on the practical management of diabetes mellitus in cats. J Feline Med Surg 2015;17(3):235\u201350."},{"issue":"2","key":"i1547-3317-62-3-65-b49","series-title":"Vet Clin North Am Small Anim Pract","first-page":"267","article-title":"Management of cats on Lente insulin: tips and traps","volume":"43","author":"Caney","year":"2013","unstructured":"Caney SM. Management of cats on Lente insulin: tips and traps. Vet Clin North Am Small Anim Pract 2013;43(2):267\u201382."},{"issue":"3","key":"i1547-3317-62-3-65-b50","series-title":"J Feline Med Surg","first-page":"205","article-title":"Feline diabetes mellitus: clinical use of long-acting glargine and detemir","volume":"16","author":"Bloom","year":"2014","unstructured":"Bloom CA, Rand J. Feline diabetes mellitus: clinical use of long-acting glargine and detemir. J Feline Med Surg 2014;16(3):205\u201315."},{"key":"i1547-3317-62-3-65-b51","series-title":"Front Vet Sci","first-page":"218","article-title":"Metabolic profiling of diabetic cats in remission","volume":"7","author":"Gottlieb","year":"2020","unstructured":"Gottlieb S, Rand J, Anderson ST,  Metabolic profiling of diabetic cats in remission. Front Vet Sci 2020;7:218."},{"issue":"4","key":"i1547-3317-62-3-65-b52","series-title":"Domest Anim Endocrinol.","first-page":"205","article-title":"The incretin effect in cats: comparison between oral glucose, lipids, and amino acids","volume":"40","author":"Gilor","year":"2011","unstructured":"Gilor C, Graves TK, Gilor S, Ridge TK, Weng HY, Dossin O. The incretin effect in cats: comparison between oral glucose, lipids, and amino acids. Domest Anim Endocrinol. 2011;40(4):205\u2013212."},{"issue":"1","key":"i1547-3317-62-3-65-b53","series-title":"Journal of Veterinary Internal Medicine.","first-page":"58","article-title":"Survival, remission, and quality of life in diabetic cats","volume":"37","author":"Rothlin\u2010Zachrisson","year":"2023","unstructured":"Rothlin\u2010Zachrisson N, \u00d6hlund M, R\u00f6cklinsberg H, Str\u00f6m Holst B. Survival, remission, and quality of life in diabetic cats. Journal of Veterinary Internal Medicine. 2023 Jan;37(1):58\u201369."},{"issue":"6","key":"i1547-3317-62-3-65-b54","series-title":"J Vet Intern Med","first-page":"1326","article-title":"Remission of diabetes mellitus in cats with diabetic ketoacidosis","volume":"22","author":"Sieber\u2010Ruckstuhl","year":"2008","unstructured":"Sieber\u2010Ruckstuhl NS, Kley S, Tschuor F,  Remission of diabetes mellitus in cats with diabetic ketoacidosis. J Vet Intern Med 2008;22(6):1326\u201332."},{"issue":"4","key":"i1547-3317-62-3-65-b55","series-title":"J Feline Med Surg","first-page":"1098612X241232546","article-title":"Frequency of diabetic remission, predictors of remission and survival in cats using a low-cost, moderate-intensity, home-monitoring protocol and twice-daily glargine","volume":"26","author":"Gottlieb","year":"2024","unstructured":"Gottlieb S, Rand JS, Anderson ST. Frequency of diabetic remission, predictors of remission and survival in cats using a low-cost, moderate-intensity, home-monitoring protocol and twice-daily glargine. J Feline Med Surg 2024;26(4):1098612X241232546."},{"issue":"2","key":"i1547-3317-62-3-65-b56","series-title":"J Vet Intern Med","first-page":"823","article-title":"Efficacy of hypophysectomy for the treatment of hypersomatotropism\u2010induced diabetes mellitus in 68 cats","volume":"35","author":"Fenn","year":"2021","unstructured":"Fenn J, Kenny PJ, Scudder CJ,  Efficacy of hypophysectomy for the treatment of hypersomatotropism\u2010induced diabetes mellitus in 68 cats. J Vet Intern Med 2021;35(2):823\u201333."},{"issue":"8","key":"i1547-3317-62-3-65-b57","series-title":"J Feline Med Surg.","first-page":"668","article-title":"Intensive blood glucose control is safe and effective in diabetic cats using home monitoring and treatment with glargine","volume":"11","author":"Roomp","year":"2009","unstructured":"Roomp K, Rand J. Intensive blood glucose control is safe and effective in diabetic cats using home monitoring and treatment with glargine. J Feline Med Surg. 2009;11(8):668\u2013682."},{"issue":"6","key":"i1547-3317-62-3-65-b58","series-title":"J Vet Intern Med.","first-page":"1314","article-title":"Predictors of clinical remission in cats with diabetes mellitus","volume":"24","author":"Zini","year":"2010","unstructured":"Zini E, Hafner M, Osto M,  Predictors of clinical remission in cats with diabetes mellitus. J Vet Intern Med. 2010;24(6):1314\u20131321."},{"key":"i1547-3317-62-3-65-b59","series-title":"J Vet Intern Med","first-page":"892","article-title":"Serum insulin-like growth factor-I concentration in cats with diabetes mellitus and acromegaly","volume":"21","author":"Berg","year":"2007","unstructured":"Berg RIM, Nelson RW, Feldman EC,  Serum insulin-like growth factor-I concentration in cats with diabetes mellitus and acromegaly. J Vet Intern Med 2007;21:892\u20138."},{"issue":"8","key":"i1547-3317-62-3-65-b60","series-title":"J Feline Med Surg","first-page":"888","article-title":"Evaluation of insulin-like growth factor-1, total thyroxine, feline pancreas-specific lipase and urinary corticoid-to-creatinine ratio in cats with diabetes mellitus in Switzerland and the Netherlands","volume":"19","author":"Schaefer","year":"2017","unstructured":"Schaefer S, Kooistra HS, Riond B,  Evaluation of insulin-like growth factor-1, total thyroxine, feline pancreas-specific lipase and urinary corticoid-to-creatinine ratio in cats with diabetes mellitus in Switzerland and the Netherlands. J Feline Med Surg 2017;19(8):888\u201396."},{"issue":"2","key":"i1547-3317-62-3-65-b61","series-title":"J Feline Med Surg","first-page":"179","article-title":"Insulin-like growth factor type 1 concentrations in hyperthyroid cats before and after treatment with thiamazole","volume":"20","author":"Rochel","year":"2018","unstructured":"Rochel D, Burger M, Nguyen P,  Insulin-like growth factor type 1 concentrations in hyperthyroid cats before and after treatment with thiamazole. J Feline Med Surg 2018;20(2):179\u2013183."},{"key":"i1547-3317-62-3-65-b62","series-title":"Domest Anim Endocrinol","first-page":"106858","article-title":"Increased insulin-like growth factor 1 concentrations in a population of non-diabetic cats with overweight\/obesity","volume":"89","author":"Miceli","year":"2024","unstructured":"Miceli DD, Jaliquias A, Gallelli MF,  Increased insulin-like growth factor 1 concentrations in a population of non-diabetic cats with overweight\/obesity. Domest Anim Endocrinol 2024;89:106858."},{"issue":"3","key":"i1547-3317-62-3-65-b63","series-title":"Res Vet Sci","first-page":"331","article-title":"Evaluation of IGF-1 levels in cats with transient and permanent diabetes mellitus","volume":"83","author":"Alt","year":"2007","unstructured":"Alt N, Kley S, Tschuor F,  Evaluation of IGF-1 levels in cats with transient and permanent diabetes mellitus. Res Vet Sci 2007;83(3):331\u20135."},{"key":"i1547-3317-62-3-65-b64","series-title":"Today\u2019s Veterinary Practice.","article-title":"The role of sodium\u2013glucose cotransporter 2 inhibitors in feline diabetes mellitus management","author":"Scott-Moncrieff","year":"2023","unstructured":"Scott-Moncrieff JC. The role of sodium\u2013glucose cotransporter 2 inhibitors in feline diabetes mellitus management. Today\u2019s Veterinary Practice. December 8, 2023. Available at: todaysveterinarypractice.com\/pharmacology\/sglt2-inhibitors-in-feline-diabetes-mellitus\/. Accessed November 11, 2025."},{"issue":"12","key":"i1547-3317-62-3-65-b65","series-title":"J Small Anim Pract","first-page":"776","article-title":"Refrigerated multi-dose insulin vials remain sterile through 6 months of use","volume":"64","author":"Berg","year":"2023","unstructured":"Berg AS, Jacob ME, Mamo LB,  Refrigerated multi-dose insulin vials remain sterile through 6 months of use. J Small Anim Pract 2023;64(12):776\u201380."},{"issue":"1","key":"i1547-3317-62-3-65-b66","series-title":"Clin Pediatr (Phila)","first-page":"69","article-title":"Accuracy and precision of low-dose insulin administration using syringes, pen injectors, and a pump","volume":"43","author":"Keith","year":"2004","unstructured":"Keith K, Nicholson D, Rogers D. Accuracy and precision of low-dose insulin administration using syringes, pen injectors, and a pump. Clin Pediatr (Phila) 2004;43(1):69\u201374."},{"issue":"2","key":"i1547-3317-62-3-65-b67","series-title":"Vet Rec","first-page":"52","article-title":"Comparisons of different measurements for monitoring diabetic cats treated with porcine insulin zinc suspension","volume":"161","author":"Martin","year":"2007","unstructured":"Martin GJ, Rand JS. Comparisons of different measurements for monitoring diabetic cats treated with porcine insulin zinc suspension. Vet Rec 2007;161(2):52\u20138."},{"issue":"2","key":"i1547-3317-62-3-65-b68","series-title":"J Vet Emerg Crit Care (San Antonio).","first-page":"263","article-title":"Retrospective evaluation of risk factors and outcome predictors in cats with diabetic ketoacidosis (1997-2007): 93 cases","volume":"25","author":"Cooper","year":"2015","unstructured":"Cooper RL, Drobatz KJ, Lennon EM, Hess RS. Retrospective evaluation of risk factors and outcome predictors in cats with diabetic ketoacidosis (1997-2007): 93 cases. J Vet Emerg Crit Care (San Antonio). 2015;25(2):263\u2013272."},{"issue":"4","key":"i1547-3317-62-3-65-b69","series-title":"Can Vet J","first-page":"426","article-title":"Role of beta-hydroxybutyric acid in diabetic ketoacidosis: a review","volume":"52","author":"Stojanovic","year":"2011","unstructured":"Stojanovic V, Ihle S. Role of beta-hydroxybutyric acid in diabetic ketoacidosis: a review. Can Vet J 2011;52(4):426\u201330."},{"issue":"11","key":"i1547-3317-62-3-65-b70","series-title":"J Feline Med Surg","first-page":"1167","article-title":"Diabetic ketoacidosis in the cat: Recognition and essential treatment","volume":"19","author":"Rudloff","year":"2017","unstructured":"Rudloff E. Diabetic ketoacidosis in the cat: Recognition and essential treatment. J Feline Med Surg 2017;19(11):1167\u201374."},{"issue":"4","key":"i1547-3317-62-3-65-b71","series-title":"J Vet Emerg Crit Care (San Antonio)","first-page":"459","article-title":"Glargine versus regular insulin protocol in feline diabetic ketoacidosis","volume":"31","author":"Zeugswetter","year":"2021","unstructured":"Zeugswetter FK, Luckschander-Zeller N, Karlovits S,  Glargine versus regular insulin protocol in feline diabetic ketoacidosis. J Vet Emerg Crit Care (San Antonio) 2021;31(4):459\u201368."},{"issue":"3","key":"i1547-3317-62-3-65-b72","series-title":"J Am Vet Med Assoc","first-page":"276","article-title":"Evaluation of six portable blood glucose meters for measuring blood glucose concentration in dogs","volume":"235","author":"Cohen","year":"2009","unstructured":"Cohen TA, Nelson RW, Kass PH,  Evaluation of six portable blood glucose meters for measuring blood glucose concentration in dogs. J Am Vet Med Assoc 2009;235(3):276\u201380."},{"key":"i1547-3317-62-3-65-b73","article-title":"AlphaTrak 3 [package insert.] Zoetis","unstructured":"AlphaTrak 3 [package insert.] Zoetis. Available at: https:\/\/www.zoetisus.com\/content\/_assets\/docs\/vmips\/package-inserts\/alphatrak-3-package-insert.pdf. Accessed November 12, 2025."},{"key":"i1547-3317-62-3-65-b74","series-title":"J Vet Intern Med","first-page":"1271","article-title":"Comparison between glucose measurements in canine whole blood, serum, and plasma","volume":"31","author":"Behrend","year":"2017","unstructured":"Behrend EN, Suchowersky ND, Carlson EA,  Comparison between glucose measurements in canine whole blood, serum, and plasma. J Vet Intern Med 2017;31:1271\u20132."},{"issue":"3","key":"i1547-3317-62-3-65-b75","series-title":"J Vet Intern Med.","first-page":"978","article-title":"Glucose concentrations after insulin-induced hypoglycemia and glycemic variability in healthy and diabetic cats","volume":"32","author":"Zini","year":"2018","unstructured":"Zini E, Salesov E, Dupont P,  Glucose concentrations after insulin-induced hypoglycemia and glycemic variability in healthy and diabetic cats. J Vet Intern Med. 2018;32(3):978\u2013985."},{"issue":"3","key":"i1547-3317-62-3-65-b76","series-title":"J Am Vet Med Assoc","first-page":"317","article-title":"Evaluation of day-to-day variability of serial blood glucose concentration curves in diabetic dogs","volume":"222","author":"Fleeman","year":"2003","unstructured":"Fleeman LM, Rand JS. Evaluation of day-to-day variability of serial blood glucose concentration curves in diabetic dogs. J Am Vet Med Assoc 2003;222(3):317\u201321."},{"issue":"3","key":"i1547-3317-62-3-65-b77","series-title":"J Feline Med Surg","first-page":"153","article-title":"Evaluation of a continuous glucose monitoring system in cats with diabetes mellitus","volume":"7","author":"Ristic","year":"2005","unstructured":"Ristic JM, Herrtage ME, Walti-Lauger SM,  Evaluation of a continuous glucose monitoring system in cats with diabetes mellitus. J Feline Med Surg 2005;7(3):153\u201362."},{"issue":"7","key":"i1547-3317-62-3-65-b78","series-title":"J Small Anim Pract","first-page":"298","article-title":"Home monitoring of blood glucose concentration by owners of diabetic dogs","volume":"44","author":"Casella","year":"2003","unstructured":"Casella M, Wess G, Hassig M,  Home monitoring of blood glucose concentration by owners of diabetic dogs. J Small Anim Pract 2003;44(7):298\u2013305."},{"issue":"8","key":"i1547-3317-62-3-65-b79","series-title":"Can Vet J","first-page":"718","article-title":"Retrospective study of owners\u2019 perception on home monitoring of blood glucose in diabetic dogs and cats","volume":"46","author":"Van de Maele","year":"2005","unstructured":"Van de Maele I, Rogier N, Daminet S. Retrospective study of owners\u2019 perception on home monitoring of blood glucose in diabetic dogs and cats. Can Vet J 2005;46(8):718\u201323."},{"issue":"7","key":"i1547-3317-62-3-65-b80","series-title":"J Am Vet Med Assoc","first-page":"1011","article-title":"Day-to-day variability of blood glucose concentration curves generated at home in cats with diabetes mellitus","volume":"230","author":"Alt","year":"2007","unstructured":"Alt N, Kley S, Haessig M,  Day-to-day variability of blood glucose concentration curves generated at home in cats with diabetes mellitus. J Am Vet Med Assoc 2007;230(7):1011\u20137."},{"issue":"4","key":"i1547-3317-62-3-65-b81","series-title":"J Vet Intern Med","first-page":"983","article-title":"Accuracy of a flash glucose monitoring system in diabetic dogs","volume":"30","author":"Corradini","year":"2016","unstructured":"Corradini S, Pilosio B, Dondi F,  Accuracy of a flash glucose monitoring system in diabetic dogs. J Vet Intern Med 2016;30(4):983\u20138."},{"issue":"6","key":"i1547-3317-62-3-65-b82","series-title":"J Feline Med Surg","first-page":"557","article-title":"Complications associated with a flash glucose monitoring system in diabetic cats","volume":"23","author":"Shoelson","year":"2021","unstructured":"Shoelson AM, Mahony OM, Pavlick M. Complications associated with a flash glucose monitoring system in diabetic cats. J Feline Med Surg 2021; 23(6):557\u201362."},{"issue":"4","key":"i1547-3317-62-3-65-b83","series-title":"J Vet Intern Med","first-page":"1703","article-title":"Validation of a flash glucose monitoring system in outpatient diabetic cats","volume":"35","author":"Shea","year":"2021","unstructured":"Shea EK, Hess RS. Validation of a flash glucose monitoring system in outpatient diabetic cats. J Vet Intern Med 2021;35(4):1703\u201312."},{"issue":"1","key":"i1547-3317-62-3-65-b84","series-title":"J Vet Intern Med","first-page":"83","article-title":"Accuracy of a flash glucose monitoring system in dogs with diabetic ketoacidosis","volume":"34","author":"Malerba","year":"2020","unstructured":"Malerba E, Cattani C, Del Baldo F,  Accuracy of a flash glucose monitoring system in dogs with diabetic ketoacidosis. J Vet Intern Med 2020;34(1):83\u201391."},{"issue":"5","key":"i1547-3317-62-3-65-b85","series-title":"J Vet Intern Med","first-page":"1703","article-title":"Assessment of the FreeStyle Libre 2 interstitial glucose monitor in hypo- and euglycemic cats","volume":"37","author":"Berg","year":"2023","unstructured":"Berg AS, Crews CD, Adin C, Alfonso-Castro A, Hill SB, Mott J, Gilor C. Assessment of the FreeStyle Libre 2 interstitial glucose monitor in hypo- and euglycemic cats. J Vet Intern Med 2023;37(5):1703\u20139."},{"issue":"3","key":"i1547-3317-62-3-65-b86","series-title":"Vet Clin North Am Small Anim Pract","first-page":"677","article-title":"Insulin therapy","volume":"25","author":"Greco","year":"1995","unstructured":"Greco DS, Broussard JD, Peterson ME. Insulin therapy. Vet Clin North Am Small Anim Pract 1995;25(3):677\u201389."},{"issue":"6","key":"i1547-3317-62-3-65-b87","series-title":"J Vet Intern Med","first-page":"360","article-title":"Serum fructosamine concentration as an index of glycemia in cats with diabetes mellitus and stress hyperglycemia","volume":"10","author":"Crenshaw","year":"1996","unstructured":"Crenshaw KL, Peterson ME, Heeb LA. Serum fructosamine concentration as an index of glycemia in cats with diabetes mellitus and stress hyperglycemia. J Vet Intern Med 1996;10(6):360\u20134. (48)"},{"issue":"1","key":"i1547-3317-62-3-65-b88","series-title":"Vet Res","first-page":"55","article-title":"Fructosamine and glycated hemoglobin in the assessment of glycaemic control in dogs","volume":"32","author":"Loste","year":"2001","unstructured":"Loste A, Marca MC. Fructosamine and glycated hemoglobin in the assessment of glycaemic control in dogs. Vet Res 2001;32(1):55\u201362."},{"issue":"3","key":"i1547-3317-62-3-65-b89","series-title":"J Vet Diagn Invest","first-page":"408","article-title":"Evaluation of a human glycated hemoglobin test in canine diabetes mellitus","volume":"31","author":"Kim","year":"2019","unstructured":"Kim NY, An J, Jeong JK,  Evaluation of a human glycated hemoglobin test in canine diabetes mellitus. J Vet Diagn Invest 2019;31(3):408\u201314."},{"issue":"2","key":"i1547-3317-62-3-65-b90","series-title":"PLoS One","first-page":"e0264275","article-title":"Relationship between HbA1c, fructosamine and clinical assessment of glycemic control in dogs","volume":"17","author":"Norris","year":"2022","unstructured":"Norris O, Schermerhorn T. Relationship between HbA1c, fructosamine and clinical assessment of glycemic control in dogs. PLoS One 2022;17(2):e0264275."}],"container-title":["Journal of the American Animal Hospital Association"],"original-title":[],"link":[{"URL":"https:\/\/jaaha.kglmeridian.com\/view\/journals\/aaha\/62\/3\/article-p65.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jaaha.kglmeridian.com\/downloadpdf\/journals\/aaha\/62\/3\/article-p65.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jaaha.kglmeridian.com\/downloadpdf\/journals\/aaha\/62\/3\/article-p65.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:30:54Z","timestamp":1783729854000},"score":1,"resource":{"primary":{"URL":"https:\/\/jaaha.kglmeridian.com\/view\/journals\/aaha\/62\/3\/article-p65.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":90,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.5326\/jaaha-ms-7572","relation":{},"ISSN":["1547-3317","0587-2871"],"issn-type":[{"value":"1547-3317","type":"electronic"},{"value":"0587-2871","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,1]]}}}